Variant report
Variant | nsv967043 |
---|---|
Chromosome Location | chr3:99944303-99944955 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:183)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr3:99944758-99945082 | A549 | lung: | n/a | n/a |
2 | CEBPB | chr3:99944603-99945094 | HepG2 | liver: | n/a | n/a |
3 | CEBPB | chr3:99944601-99945082 | HepG2 | liver: | n/a | n/a |
4 | CEBPB | chr3:99944770-99945039 | HepG2 | liver: | n/a | n/a |
5 | CEBPB | chr3:99944786-99945059 | K562 | blood: | n/a | n/a |
6 | CEBPB | chr3:99944686-99945100 | HepG2 | liver: | n/a | n/a |
7 | CTCF | chr3:99944474-99944515 | Fibrobl | skin: | n/a | n/a |
8 | EP300 | chr3:99944894-99945045 | HepG2 | liver: | n/a | n/a |
9 | FOXA2 | chr3:99944649-99944925 | HepG2 | liver: | n/a | n/a |
10 | MAX | chr3:99944880-99944888 | HepG2 | liver: | n/a | n/a |
11 | POLR2A | chr3:99944236-99944329 | A549 | lung: | n/a | n/a |
12 | POLR2A | chr3:99944227-99944357 | A549 | lung: | n/a | n/a |
13 | POLR2A | chr3:99944088-99944306 | Hela-S3 | cervix: | n/a | n/a |
14 | SMC3 | chr3:99944795-99944961 | HepG2 | liver: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:99944324-99944374 | RPTEC | kidney: | n/a |
2 | chr3:99944461-99944511 | LNCaP | prostate: | n/a |
3 | chr3:99944331-99944381 | AG04450 | lung: | fetal |
4 | chr3:99944324-99944374 | H1-hESC | embryonic stem cell: | embryo |
5 | chr3:99944461-99944511 | NHDF-neo | bronchial: | n/a |
6 | chr3:99944324-99944374 | IMR90 | lung: | fetal |
7 | chr3:99944324-99944374 | HCPEpiC | choroid plexus: | n/a |
8 | chr3:99944461-99944511 | GM19239 | blood: | n/a |
9 | chr3:99944331-99944381 | ECC-1 | luminal epithelium: | n/a |
10 | chr3:99944324-99944374 | ProgFib | skin: | n/a |
11 | chr3:99944324-99944374 | HepG2 | liver: | n/a |
12 | chr3:99944461-99944511 | HRE | kidney: | n/a |
13 | chr3:99944324-99944374 | NHBE | bronchial: | n/a |
14 | chr3:99944324-99944374 | SAEC | small airway: | n/a |
15 | chr3:99944461-99944511 | GM12891 | blood: | n/a |
16 | chr3:99944324-99944374 | HIPEpiC | eye: | n/a |
17 | chr3:99944331-99944381 | GM19239 | blood: | n/a |
18 | chr3:99944331-99944381 | HNPCEpiC | eye: | n/a |
19 | chr3:99944461-99944511 | PFSK-1 | brain: | n/a |
20 | chr3:99944461-99944511 | K562 | blood: | n/a |
21 | chr3:99944331-99944381 | HRPEpiC | eye: | n/a |
22 | chr3:99944331-99944381 | BE2_C | brain: | n/a |
23 | chr3:99944461-99944511 | GM12892 | blood: | n/a |
24 | chr3:99944331-99944381 | HMEC | breast: | n/a |
25 | chr3:99944461-99944511 | SK-N-SH_RA | brain: | n/a |
26 | chr3:99944324-99944374 | HEK293 | kidney: | embryo |
27 | chr3:99944461-99944511 | H1-hESC | embryonic stem cell: | embryo |
28 | chr3:99944324-99944374 | HCM | heart: | n/a |
29 | chr3:99944461-99944511 | Jurkat | blood: | n/a |
30 | chr3:99944461-99944511 | NHBE | bronchial: | n/a |
31 | chr3:99944461-99944511 | ovcar-3 | ovarian: | n/a |
32 | chr3:99944324-99944374 | GM12878 | blood: | n/a |
33 | chr3:99944324-99944374 | AG04449 | skin: | fetal |
34 | chr3:99944324-99944374 | Jurkat | blood: | n/a |
35 | chr3:99944461-99944511 | Caco-2 | colon: | n/a |
36 | chr3:99944331-99944381 | HPAEpiC | pulmonary alveolar: | n/a |
37 | chr3:99944461-99944511 | AG10803 | skin: | n/a |
38 | chr3:99944324-99944374 | GM06990 | blood: | n/a |
39 | chr3:99944331-99944381 | GM12891 | blood: | n/a |
40 | chr3:99944461-99944511 | MCF10A-Er-Src | breast: | n/a |
41 | chr3:99944461-99944511 | AG09309 | skin: | n/a |
42 | chr3:99944331-99944381 | K562 | blood: | n/a |
43 | chr3:99944331-99944381 | ovcar-3 | ovarian: | n/a |
44 | chr3:99944461-99944511 | PrEC | prostate: | n/a |
45 | chr3:99944461-99944511 | SK-N-MC | brain: | n/a |
46 | chr3:99944331-99944381 | HIPEpiC | eye: | n/a |
47 | chr3:99944461-99944511 | NH-A | brain: | n/a |
48 | chr3:99944324-99944374 | AG09309 | skin: | n/a |
49 | chr3:99944324-99944374 | A549 | lung: | n/a |
50 | chr3:99944461-99944511 | HRPEpiC | eye: | n/a |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000238377 | TF binding region |
ENSG00000238377 | CpG island |
ENSG00000036054 | chromatin interactions |
ENSG00000238377 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs561587820 | chr3:99944304-99944305 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs545053413 | chr3:99944321-99944322 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs531875239 | chr3:99944323-99944324 | Enhancers | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs544226437 | chr3:99944334-99944335 | Enhancers | TF binding regionCpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs562344473 | chr3:99944343-99944344 | Enhancers | TF binding regionCpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs533090510 | chr3:99944364-99944365 | Enhancers | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs1684244 | chr3:99944376-99944377 | Enhancers | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs17213695 | chr3:99944381-99944382 | Enhancers | CpG islandChromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs566185983 | chr3:99944392-99944393 | Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs527504949 | chr3:99944404-99944405 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs548734499 | chr3:99944436-99944437 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs567587049 | chr3:99944468-99944469 | Weak transcription Enhancers | CpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs572440790 | chr3:99944478-99944479 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs537728406 | chr3:99944496-99944497 | Weak transcription Enhancers | TF binding regionCpG islandChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs556566453 | chr3:99944528-99944529 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs571540249 | chr3:99944546-99944547 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs538994419 | chr3:99944566-99944567 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs554309927 | chr3:99944582-99944583 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs35805111 | chr3:99944634-99944635 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs139888195 | chr3:99944636-99944637 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs555183683 | chr3:99944681-99944682 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs59233020 | chr3:99944694-99944695 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs543750688 | chr3:99944709-99944710 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs565534871 | chr3:99944711-99944712 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs560344081 | chr3:99944724-99944725 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs368660135 | chr3:99944727-99944728 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs376582140 | chr3:99944759-99944760 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs183801943 | chr3:99944760-99944761 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs187895316 | chr3:99944767-99944768 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs527371718 | chr3:99944794-99944795 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs548794696 | chr3:99944835-99944836 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs567344041 | chr3:99944888-99944889 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs146199244 | chr3:99944892-99944893 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs193007033 | chr3:99944907-99944908 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs139114946 | chr3:99944920-99944921 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs183753673 | chr3:99944941-99944942 | Enhancers Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21129771 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Amyotrophic lateral sclerosis | 20685689 | CNVD |
Melanoma | 20877625 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:99944200-99944400 | Enhancers | Placenta | Placenta |
2 | chr3:99944400-99945200 | Weak transcription | Placenta | Placenta |
3 | chr3:99944400-99945400 | Enhancers | HepG2 | liver |
4 | chr3:99944600-99945600 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
5 | chr3:99944600-99946600 | Enhancers | K562 | blood |
6 | chr3:99944800-99946400 | Enhancers | Psoas Muscle | Psoas |
7 | chr3:99944800-99946600 | Enhancers | HSMMtube | muscle |
8 | chr3:99944800-99946800 | Enhancers | NHDF-Ad | bronchial |
9 | chr3:99944800-99946800 | Enhancers | NHLF | lung |